SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023099
Filing Date
2018-09-13
Accepted
2018-09-13 16:25:40
Documents
5
Period of Report
2018-09-13
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180913.htm 8-K 38821
2 EX-1.1 xene-ex11_6.htm EX-1.1 425205
3 EX-5.1 xene-ex51_161.htm EX-5.1 11969
4 GRAPHIC gfgmbeed1cs2000002.jpg GRAPHIC 14552
5 GRAPHIC gfgmbeed1cs2000001.jpg GRAPHIC 14552
  Complete submission text file 0001564590-18-023099.txt   517569
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 181069136
SIC: 2834 Pharmaceutical Preparations